These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. Dagnino L; Drouin J; Nemer M Mol Endocrinol; 1991 Sep; 5(9):1292-300. PubMed ID: 1837590 [TBL] [Abstract][Full Text] [Related]
30. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Allcock GH; Venema RC; Pollock DM Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985 [TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway. Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539 [TBL] [Abstract][Full Text] [Related]
32. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody. Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603 [TBL] [Abstract][Full Text] [Related]
33. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. Ndisang JF; Jadhav A J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817 [TBL] [Abstract][Full Text] [Related]
34. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats. Bae EH; Kim IJ; Ma SK; Kim SW Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859 [TBL] [Abstract][Full Text] [Related]
35. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats. Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357 [TBL] [Abstract][Full Text] [Related]
36. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F Hypertension; 1994 Aug; 24(2):195-204. PubMed ID: 8039844 [TBL] [Abstract][Full Text] [Related]
37. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats. Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359 [TBL] [Abstract][Full Text] [Related]
38. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation. Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146 [TBL] [Abstract][Full Text] [Related]